期刊文献+

wt-P53蛋白对人瘢痕疙瘩成纤维细胞端粒酶活性的影响(英文) 被引量:2

EFFECT OF wt-P53 PROTEIN ON TELOMERASE ACTIVITY IN KELOID FIBROBLASTS
下载PDF
导出
摘要 目的 探讨wt-P53蛋白对人瘢痕疙瘩成纤维细胞(keloidfibroblasts,KFBS)端粒酶活性的影响;明确在人KFBs中wt-P53蛋白与端粒酶活性之间的相互关系。方法 将来源于人瘢痕疙瘩组织的KFBs随机分成两组,转染组采用腺病毒介导法将野生型Wt-p53基因转染至人KFBs;非转染组KFBs未进行野生型wt-p53基因转染。转染48h后,采用间接免疫荧光法和Western blotting法检测KFBs wt-P53蛋白的表达;并于转染后1~7d,采用TRAP—ELISA法检测KFBs端粒酶活性。结果两组均有wt-P53蛋白表达,转染组Wt-P53蛋白表达明显高于非转染组;转染后1~7d,转染组端粒酶活性均明显低于非转染组(P〈O.05)。结论 wt-P53蛋白能够抑制人KFBs端粒酶活性。 Objective To evaluated the role of wt-P53 protein in telomerase regulation in keloid fibroblasts(KFBs). Methods The fibroblasts were derived from human keloid tissue which was proved by pathological diagnosis. KFBs were divided into 2 groups, the transfection group and the untransfection group, wt-p53 gene was transfected into the fibrohlasts by adenovirus vectors in the transfection group. The KFBs untransfected with wt-p53 gene served as control (untransfection group). After 48 hours of transfection, the expression of wt-P53 protein was analyzed by both Western blotting and immunofluorescenee method, respectively. The telomerase activity was evaluated by TRAP-ELISA after 1-7 days of transfeetion. Results All the KFBs from 2 groups expressed wt-P53 protein. But the expression level of wt-P53 protein in the transfection group was significantly higher than that in the untransfection group. At the same time of high expression of wt-P53 protein, the telomerase activity of KFBs in transfection group was significantly lower than that in the untransfection group( P 〈 0.05). Conclusion High level expression of wt-P53 protein can transiently inhibit the telomemse activity of KFBs.
出处 《中国修复重建外科杂志》 CAS CSCD 北大核心 2007年第7期702-706,共5页 Chinese Journal of Reparative and Reconstructive Surgery
关键词 wt-P53蛋白 端粒酶活性 瘢痕疙瘩 成纤维细胞 wt-P53 protein Telomerase activity Keloid Fibroblasts
  • 相关文献

参考文献18

  • 1刘旺.正常皮肤和瘢痕疙瘩中端粒酶的表达[J].中国皮肤病杂志,2003,10(36):589-590.
  • 2Reisman D,Loging WT.Transcriptional regulation of the p53 tumor suppressor gene.Semin Cancer Biol,1998,8(5):317-324.
  • 3Wang Q,Shaltiel S.Distal hinge of plasminogen activator inhibitor-1 involves its latency transition and specificities toward serine proteases.BMC Biochem,2003,4:5.
  • 4Odet F,Guyot R,Leduque P,et al.Evidence for similar expression of protein C inhibitor and the urokinase-type plasminogen activator system during mouse testis development.Endocrinology,2004,145(3):1481-1489.
  • 5付小兵,程飚.进一步重视病理性瘢痕发生机制的研究[J].中国修复重建外科杂志,2005,19(1):1-5. 被引量:35
  • 6Bar-Or A,Nuttall RK,Duddy M,et al.Analyses of all matrix metalloproteinase members in leukocytes emphasize monocytes as major inflammatory mediators in multiple sclerosis.Brain,2003,126(Pt 12):2738-2749.
  • 7Helene B,Sophie G,Franck Z,et al.Matrix metalloproteinase 3 polymorphism:a predictive factor of response to neoadjuvant chemotherapy in head and neck squamous cell carcinoma.Clin Cancer Res,2004,10(8):2594-2599.
  • 8Jiahui Zhang,Yifan Tu,Sallie Smith-Schneider.Activation of p53,inhibition of telomerase activity and induction of estrogen receptor beta are associated with the anti-growth effects of combination of ovarian hormones and retinoid in immortalized human mammary epithelial cells.Cancer Cell International,2005,5(6):1186-1475.
  • 9Catterall JB,Cawston TE.Drugs in development:bisphosphonates and metalloproteinase inhibitors.Arthritis Res Ther,2003,5(1):12-24.
  • 10Podgorski I,Sloane BF.Cathepsin B and its role(s) in cancer progression.Biochem Soc Symp,2003,(70):263-276.

二级参考文献1

共引文献34

同被引文献32

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部